Senate President Joe Negron Appoints Dr. Richard Houghten to the Biomedical Research Advisory Council for the State of Florida's Department of Health

July 12, 2017

Dr. Richard A. Houghten, CEO & Founder of Torrey Pines Institute for Molecular Studies was appointed by Senate President Joe Negron to the Biomedical Research Advisory Board for the State of Florida's Department of Health for a three year term effective July 12, 2017. The Biomedical Research Advisory Council advises the State Surgeon General as to the direction and scope of the James and Esther King Biomedical Research Program and the Bankhead-Coley Cancer Research Program. Dr. Houghten shared "It is an honor to be appointed by Senate President Joe Negron. I look forward to working with the other members of the Biomedical Research Advisory Board."

Dr. Houghten has 45 years of scientific drug discovery experience with 500 scientific peer reviewed publications and 80 issued U.S. patents. Over his career, he has received 25 National Institutes of Health (NIH) grants. Dr. Houghten has served on several NIH Study Sections. He has founded five for profit companies including one publicly traded. Dr. Houghten is an American Association of Pharmaceutical Sciences Fellow, American Association of The Advancement of Science Fellow, and a Charter Fellow of the National Academy of Inventors. His many awards include the 2004 Ralph Hirschmann Award in Peptide Chemistry by the American Chemical Society, the 2005 Bruce Merrifield Award by the American Peptide Society, and UCSD Connect’s Athena Pinnacle Award for Empowering Women in the Workplace

###

Torrey Pines Institute for Molecular Studies is a 501(c)(3) organization with research centers in Port St. Lucie, FL and San Diego, CA. Scientists conduct research in fields associated with a wide variety of major medical conditions, including multiple sclerosis, cancer, heart disease, Types I and II diabetes, macular degeneration, pain management, Alzheimer's, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery.

Contact:
TPIMS News
Torrey Pines Institute for Molecular Studies
This email address is being protected from spambots. You need JavaScript enabled to view it.
11350 SW Village Pkwy
Port St. Lucie, FL 34987
Phone: (772) 345-4587